GLP-1 therapies target heart, kidney risks in diabetes
India's diabetes care is shifting beyond blood sugar control as GLP-1 receptor agonists show promise in protecting heart and kidney health. With over 100 million adults living with type 2 diabetes, a…









































Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.